Publication | Closed Access

Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells

Snt-1/frs2 PhosphotyrosineTumor BiologySignaling PathwayEndocrine-related CancerReceptor Tyrosine KinaseFibroblast Growth FactorBreast CancerMap KinaseCell BiologyAntiestrogen Resistant GrowthMedicineRadiation OncologyCell SignalingTumor MicroenvironmentCancer ResearchCancer Growth